Parenteral and oral pharmacotherapy in prevention of osteoporotic fractures in postmenopausal osteoporosis

被引：1
|
作者：
Pawlak-Bus, Katarzyna [1 ,2 ]
Leszczynski, Piotr [1 ,2 ]
机构：
[1] Wielospecjalisty Szpital J Strusia, Oddzial Reumatol & Osteoporozy, PL-61001 Poznan, Poland
[2] Uniwersytet Med Karola Marcinkowskiego, Klin Reumatol & Rehabil, Pracownia Chorob Metab Kosci & Tkanki Lacznej, Poznan, Poland
来源：
PRZEGLAD MENOPAUZALNY | 2013年 / 12卷 / 03期
关键词：
postmenopausal osteoporosis; fracture prevention; bisphosphonates; denosumab; strontium ranelate; raloxifene; teriparatide;
D O I：
10.5114/pm.2013.36598
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Currently available drugs for the management of postmenopausal osteoporosis can confuse clinicians in daily practice. The number of new oral and therapeutic agents with a different mechanism of action can make a clinical decision to start more complex treatment than previously. This may confirm that in order to know how, when and whom to treat in postmenopausal osteoporosis, specific recommendations based on medical scientific evidence are needed. This manuscript offers compact and easily available information about antiresorptive drugs which can be used by physicians in clinical practice.
引用
收藏
页码：271 / 277
页数：7
相关论文
共 50 条
  • [21] Prevention of falls and osteoporotic fractures in postmenopausal breast cancer survivors.
    Waltman, N
    Gross, G
    Lindsey, A
    Ott, C
    Twiss, J
    Berg, K
    ONCOLOGY NURSING FORUM, 2006, 33 (02) : 402 - 402
  • [22] An evaluation of the NICE guidance for the prevention of osteoporotic fragility fractures in postmenopausal women
    Kanis J.A.
    McCloskey E.V.
    Jonsson B.
    Cooper A.
    Ström O.
    Borgström F.
    Archives of Osteoporosis, 2010, 5 (1-2) : 19 - 48
  • [23] Prevention of vertebral fractures by strontium ranelate in postmenopausal women with osteoporosis
    Juliet Compston
    Osteoporosis International, 2005, 16 : S4 - S6
  • [24] Osteoporotic Fractures in Postmenopausal Women
    Heidenreich, Robyn
    Lee, Ruth
    Shil, Asit B.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2017, 65 (03) : e76 - e76
  • [25] The clinical potential of romosozumab for the prevention of fractures in postmenopausal women with osteoporosis
    Solling, Anne Sophie Koldkjaer
    Harslof, Torben
    Langdahl, Bente
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2018, 10 (5-6) : 105 - 115
  • [26] Prevention of vertebral fractures by strontium ranelate in postmenopausal women with osteoporosis
    Compston, J
    OSTEOPOROSIS INTERNATIONAL, 2005, 16 (Suppl 1) : S4 - S6
  • [27] Denosumab for Prevention of Fractures in Postmenopausal Women With Osteoporosis EDITORIAL COMMENT
    Cummings, Steven R.
    Martin, Javier San
    McClung, Michael R.
    Siris, Ethel S.
    Eastell, Richard
    Reid, Ian R.
    Delmas, Pierre
    Zoog, Holly B.
    Austin, Matt
    Wang, Andrea
    Kutilek, Stepan
    Adami, Silvano
    Zanchetta, Jose
    Libanati, Cesar
    Siddhanti, Suresh
    Christiansen, Claus
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2009, 64 (12) : 805 - 807
  • [28] Indirect comparison of teriparatide, denosumab, and oral bisphosphonates for the prevention of vertebral and nonvertebral fractures in postmenopausal women with osteoporosis
    Zhang, Lanling
    Pang, Yafei
    Shi, Yeqing
    Xu, Meijuan
    Xu, Xia
    Zhang, Ju
    Ji, Lianmei
    Zhao, Dongbao
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (09): : 1021 - 1025
  • [29] EPIDEMIOLOGY OF OSTEOPOROSIS AND OSTEOPOROTIC FRACTURES
    CUMMINGS, SR
    KELSEY, JL
    NEVITT, MC
    ODOWD, KJ
    EPIDEMIOLOGIC REVIEWS, 1985, 7 : 178 - 208
  • [30] The cost-effectiveness of calcium and vitamin D or hormone replacement therapy in the prevention of osteoporosis and osteoporotic fractures in Canadian postmenopausal women
    Papadimitropoulos, EA
    Blackhouse, G
    Goeree, R
    Coyte, PC
    Josse, RG
    Adachi, JD
    Greenwood, CE
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S84 - S85
12345